Skip to main content

Market Overview

Stifel Downgrades Aviv REIT After Exceeding Price Target


Stifel downgraded Aviv REIT Inc (NYSE: AVIV) from Buy to Hold in a report issued Monday.

“Aviv agreed to be acquired by Omega Healthcare Investors for $34.97, a 16 percent premium, in a stock for stock transactions. We are moving from Buy to Hold, having exceeded our price target,” according to analyst Chad Vanacore.

The report calculated “a 6.7 percent implied cap rate on the portfolio, which seems relatively full priced for skilled nursing where individual assets can be acquired for 8-10 percent yields. We see this as an indication of the value of Aviv's ability to source deals and its attractive portfolio of diverse operators. In a larger sense, the transaction affirms portfolio premiums across the healthcare REIT universe.”

The report concluded by noting that the firm “initiated on September 10 with a Buy rating and $31 price target under the thesis that Aviv could source accretive transactions and grow faster than its peers. Our thesis has been borne out in the third quarter and, in light of Aviv's impending acquisition by Omega, we have exceeded that target and are moving to a Hold rating.”

Aviv REIT recently traded at $34.04, up 0.92 percent.

Latest Ratings for AVIV

Feb 2015CitigroupMaintainsNeutral
Nov 2014RBC CapitalDowngradesOutperformSector Perform
Nov 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for AVIV
View the Latest Analyst Ratings


Related Articles (AVIV)

View Comments and Join the Discussion!

Posted-In: Chad Vanacore StifelAnalyst Color Downgrades Analyst Ratings

Latest Ratings

VZIOWells FargoInitiates Coverage On31.0
OMWells FargoInitiates Coverage On63.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at